Device VCs not Immune to Crisis
This article was originally published in Start Up
Executive Summary
The difficulties on Wall Street are washing down to the private market causing medical device VCs to reconsider investment strategies and exiting routes.
You may also be interested in...
Has VC Lost Its Appetite for Risk?
It's trendy to question whether the tried-and-true model of venture capital is broken. Specifically, is the economic system that relies on IPOs or acquisitions still wired to reward the risks taken by venture capitalists? But an even more worrisome concern emerged during last month's annual meeting of the National Venture Capital Association-are VCs themselves still wired to take risk?
Has VC Lost Its Appetite for Risk?
It's trendy to question whether the tried-and-true model of venture capital is broken. Specifically, is the economic system that relies on IPOs or acquisitions still wired to reward the risks taken by venture capitalists? But an even more worrisome concern emerged during last month's annual meeting of the National Venture Capital Association-are VCs themselves still wired to take risk?
Device CEOs Who Find The Funding
The financial world may be in crisis, but top-tier medical device companies can still raise capital. But at what price? Four medical device execs answer those questions and many more.